Novel drug delivery systems : (Record no. 96013)

000 -LEADER
fixed length control field 05257cam a22004697i 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260727151748.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 260709s2025 nju o 000 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119852285
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119852476
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119852471
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119852445
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119852447
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119852469
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119852463
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781119852285
Qualifying information hardcover
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1119852285
Qualifying information hardcover
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1482532592
035 #9 - SYSTEM CONTROL NUMBER
System control number (OCLCCM-Owned)1482532592
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS199.5
Item number .N68 2025
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 23
Classification number 615.6
245 00 - TITLE STATEMENT
Title Novel drug delivery systems :
Remainder of title fundamentals and applications /
Statement of responsibility, etc edited by Mehrdad Hamidi and Mahsa Sayed Tabatabaei.
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken, NJ :
Name of publisher, distributor, etc John WIley & Sons, Inc. ;
Place of publication, distribution, etc Beverly, MA :
Name of publisher, distributor, etc Scrivener Publishing LLC,
Date of publication, distribution, etc [2025]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 8# - CONTENTS
Formatted contents note Cover -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- Chapter 1 Introduction to Novel Drug Delivery Systems -- 1.1 Historical Background -- 1.2 Definition, Terminology, and Taxonomy -- 1.3 Novel Drug Delivery Systems: Why, How, and What to Deliver? -- 1.3.1 Why Delivery? -- 1.3.1.1 Liberation -- 1.3.1.2 Absorption -- 1.3.1.3 Distribution -- 1.3.1.4 Metabolism -- 1.3.1.5 Excretion -- 1.3.2 How to Deliver? -- 1.3.2.1 Drug Delivery Barriers -- 1.3.2.2 Overcoming Strategies -- 1.3.2.3 Designing Criteria of NDDSs -- 1.3.3 What to Deliver? -- 1.3.3.1 Small Molecules -- 1.3.3.2 Biopharmaceuticals -- References -- Chapter 2 Novel Drug Delivery Systems: Approach to the Market -- 2.1 Introduction -- 2.2 Novel Drug Delivery Systems Global Market -- 2.2.1 Macroeconomic Indicators Affecting the Market Growth -- 2.2.2 Novel Drug Delivery Systems -- 2.2.3 Key Market Trends
520 8# - SUMMARY, ETC.
Summary, etc This book serves as a unique resource on the field of novel drug delivery systems (NDDSs), catering to both academic audiences (researchers, teachers, students) and industry professionals (pharmaceutical policymakers, managers, R&D, regulatory, business development, and marketing) involved in NDDSs. The evolving nature of diseases and the emergence of new health complications have driven a significant shift in drug therapy. Coupled with changes in human lifestyles and economic conditions, these factors have compelled the pharmaceutical industry to develop novel, efficient, and affordable drug products. The rise of promising technologies aimed at enhancing therapeutic performance further underscores the importance of novel drug delivery systems (NDDSs), making this field one of the most dynamic in pharmaceutical sciences today. This book offers a comprehensive exploration of NDDS applications, catering to both academic and industry professionals. It is designed to be both user-friendly and thorough, meeting the needs of diverse readers-from those seeking practical insights to those delving deeply into the field's various sectors. The content has been meticulously compiled, organized, and analyzed by a team of experts to ensure accuracy, relevance, and currency. The book provides up-to-date information suitable for a broad audience, reflecting the wide scope of the NDDS field. The first section covers the foundational principles of NDDS, including their scientific and therapeutic basis, as well as the epidemiological and economic trends driving their development. Subsequent sections explore market-oriented aspects, such as global trends and projections. Chapters 3 to 12 present a taxonomy of NDDS categorized by their routes of administration. The book concludes with a forward-looking report on the potential future directions of NDDS. Written in clear, concise language, the book is accessible to non-native English readers, ensuring broad usability. Original figures, created by experts with scientific and graphic design expertise, enhance the reading experience and aid in understanding complex concepts. Audience A wide variety of professional readers from universities and other research institutions to health industries (industrial pharmaceutical and related), to the relevant high-tech startups to health and pharma policymakers and managers will be among the audiences of this book.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on online resource; title from digital title page (viewed on January 08, 2025).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug delivery systems.
Authority record control number http://id.loc.gov/authorities/subjects/sh88007108
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hamidi, Mehrdad,
Relator term editor.
Real World Object URI https://id.oclc.org/worldcat/entity/E39PCjx7XGb7jtPCFggqbWGVwd
Authority record control number http://id.loc.gov/authorities/names/n2011050268
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tabatabaei, Mahsa Sayed,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
International Standard Book Number 1119852285
-- 9781119852285
Record control number (OCoLC)1286954631
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://onlinelibrary.wiley.com/doi/book/10.1002/9781119852476
Link text Full text is available at Wiley Online Library. Click here to view.
942 ## - ADDED ENTRY ELEMENTS
Source of classification or shelving scheme
Item type EBOOK
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Use restrictions Not for loan Permanent Location Current Location Date acquired Full call number Date last seen Price effective from Item type
        In Process   COLLEGE LIBRARY COLLEGE LIBRARY 2026-07-09 615.6 N8573 2025 2026-07-09 2026-07-09 EBOOK

Powered by Koha